Fabbri F - Search Results

1

The Use of Antigenic SARS-CoV-2 Point-of-Care Test: The Italian Pediatric Real-Life Experience.

Ferrari F, Civitelli F, Ardenti Morini F, Buonaiuto FAC, Frega G, Fabbri F, Ioppi M, Maione A, Minniti De Simeonibus E, Soscia F, Torre P, Toselli F, Cortis E. Ferrari F, et al. Among authors: fabbri f. Clin Pediatr (Phila). 2022 Jan;61(1):34-41. doi: 10.1177/00099228211053916. Epub 2021 Nov 8. Clin Pediatr (Phila). 2022. PMID: 34743573

2

The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.

Cox MC, Pelliccia S, Marcheselli L, Battistini R, Arcari A, Borza PA, Patti C, Casaroli I, di Landro F, Di Napoli A, Fabbri F, Caridi M, Tafuri A, Bocci G, Musuraca G. Cox MC, et al. Among authors: fabbri f. Invest New Drugs. 2019 Jun;37(3):548-558. doi: 10.1007/s10637-019-00769-5. Epub 2019 Apr 26. Invest New Drugs. 2019. PMID: 31028663

3

Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.

Cox MC, Musuraca G, Battistini R, Casaroli I, Zoli V, Anticoli-Borza P, Arcari A, Naso V, di Landro F, Fabbri F, Tafuri A, Bocci G, Merli F. Cox MC, et al. Among authors: fabbri f. Br J Haematol. 2018 Dec;183(5):819-822. doi: 10.1111/bjh.15039. Epub 2017 Nov 28. Br J Haematol. 2018. PMID: 29193017 Free article. No abstract available.

4

Patients with a history of infection and voiding dysfunction are at risk for recurrence after successful endoscopic treatment of vesico ureteral reflux and deserve long-term follow up.

Coletta R, Olivieri C, Briganti V, Perrotta ML, Oriolo L, Fabbri F, Calisti A. Coletta R, et al. Among authors: fabbri f. Urol Ann. 2012 Jan;4(1):19-23. doi: 10.4103/0974-7796.91616. Urol Ann. 2012. PMID: 22346096 Free PMC article.

5

Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone.

Burgio SL, Conteduca V, Menna C, Carretta E, Rossi L, Bianchi E, Kopf B, Fabbri F, Amadori D, De Giorgi U. Burgio SL, et al. Among authors: fabbri f. Endocr Relat Cancer. 2014 May 8;21(3):487-93. doi: 10.1530/ERC-14-0071. Print 2014 Jun. Endocr Relat Cancer. 2014. PMID: 24741024

6

A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer.

Pietri E, Andreis D, Fabbri F, Menna C, Schirone A, Kopf B, Rocca A, Amadori D, De Giorgi U. Pietri E, et al. Among authors: fabbri f. Oncologist. 2015 Mar;20(3):239-40. doi: 10.1634/theoncologist.2014-0326. Epub 2015 Jan 30. Oncologist. 2015. PMID: 25637379 Free PMC article. Clinical Trial.

7

In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells.

Ulivi P, Arienti C, Zoli W, Scarsella M, Carloni S, Fabbri F, Tesei A, Chiadini E, Orlandi A, Passeri D, Zupi G, Milandri C, Silvestrini R, Amadori D, Leonetti C. Ulivi P, et al. Among authors: fabbri f. Curr Cancer Drug Targets. 2010 Sep;10(6):600-10. doi: 10.2174/156800910791859489. Curr Cancer Drug Targets. 2010. PMID: 20491617 Review.

8

Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone.

De Giorgi U, Caroli P, Burgio SL, Menna C, Conteduca V, Bianchi E, Fabbri F, Carretta E, Amadori D, Paganelli G, Matteucci F. De Giorgi U, et al. Among authors: fabbri f. Oncotarget. 2014 Dec 15;5(23):12448-58. doi: 10.18632/oncotarget.2558. Oncotarget. 2014. PMID: 25504434 Free PMC article. Clinical Trial.

9

RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study.

Mercatali L, Ricci M, Scarpi E, Serra P, Fabbri F, Ricci R, Liverani C, Zanoni M, Zoli W, Maltoni R, Gunelli E, Amadori D, Ibrahim T. Mercatali L, et al. Among authors: fabbri f. Int J Mol Sci. 2013 May 23;14(6):10683-93. doi: 10.3390/ijms140610683. Int J Mol Sci. 2013. PMID: 23702841 Free PMC article. Clinical Trial.

10

Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies.

Passardi A, Maltoni R, Milandri C, Cecconetto L, Massa I, Zoli W, Tesei A, Fabbri F, Nanni O, Amadori D. Passardi A, et al. Among authors: fabbri f. Oncology. 2007;72(1-2):118-24. doi: 10.1159/000111130. Epub 2007 Nov 15. Oncology. 2007. PMID: 18004083 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

690 results

Search Page